Mandate

Vinge advises Industrifonden in connection with investment in Smartfish

September 18, 2013

Industrifonden is investing SEK 35 million in the Norwegian company, Smartfish, which develops Omega 3 drinks within the field of clinical nutrition. The current owner, Investinor and private investors are also participating in the new issue valued at approximately SEK 80 million. The money will primarily be used for clinical trials and future international expansion. Smartfish develops prescription-based Omega 3-enriched drinks in the form of fruit juice for, e.g. cancer patients, who often develop cachexia, i.e. emaciation caused by significant, long-term malnourishment. At the same time, a new product for Alzheimer patients is being developed. The company holds a patented method which makes it possible to introduce high doses of Omega 3 fatty acid into the juice without affecting its taste.

Smartfish is headquartered in Oslo, although production occurs in Sweden. The company has recently been awarded a procurement contract pertaining to clinical nutrition in Skåne, which will be launched in Sweden this autumn. As a result of the capital infusion, an R&D centre will be established in Stockholm.

The investment in Starfish is the first stage of a recently commenced life science co-operation between Industrifonden and the Norwegian investment enterprise, Investinor. The aim is to give attractive life science companies access to international capital.

Vinge’s team consisted of partner Johan Larsson and associate Alexandra Kempe.   

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025